BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32712628)

  • 1. Cell-cycle-dependent phosphorylation of RRM1 ensures efficient DNA replication and regulates cancer vulnerability to ATR inhibition.
    Shu Z; Li Z; Huang H; Chen Y; Fan J; Yu L; Wu Z; Tian L; Qi Q; Peng S; Wei C; Xie Z; Li X; Feng Q; Sheng H; Li G; Wei D; Shan C; Chen G
    Oncogene; 2020 Aug; 39(35):5721-5733. PubMed ID: 32712628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the ATR-CHK1 Pathway in Ewing Sarcoma Cells Causes DNA Damage and Apoptosis via the CDK2-Mediated Degradation of RRM2.
    Koppenhafer SL; Goss KL; Terry WW; Gordon DJ
    Mol Cancer Res; 2020 Jan; 18(1):91-104. PubMed ID: 31649026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTORC2 regulates ribonucleotide reductase to promote DNA replication and gemcitabine resistance in non-small cell lung cancer.
    Tian L; Chen C; Guo Y; Zhang F; Mi J; Feng Q; Lin S; Xi N; Tian J; Yu L; Chen Y; Cao M; Lai C; Fan J; Zhang Y; Chen G
    Neoplasia; 2021 Jul; 23(7):643-652. PubMed ID: 34126361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribonucleotide Reductase Requires Subunit Switching in Hypoxia to Maintain DNA Replication.
    Foskolou IP; Jorgensen C; Leszczynska KB; Olcina MM; Tarhonskaya H; Haisma B; D'Angiolella V; Myers WK; Domene C; Flashman E; Hammond EM
    Mol Cell; 2017 Apr; 66(2):206-220.e9. PubMed ID: 28416140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV31 utilizes the ATR-Chk1 pathway to maintain elevated RRM2 levels and a replication-competent environment in differentiating Keratinocytes.
    Anacker DC; Aloor HL; Shepard CN; Lenzi GM; Johnson BA; Kim B; Moody CA
    Virology; 2016 Dec; 499():383-396. PubMed ID: 27764728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting IGF Perturbs Global Replication through Ribonucleotide Reductase Dysfunction.
    Rieunier G; Wu X; Harris LE; Mills JV; Nandakumar A; Colling L; Seraia E; Hatch SB; Ebner DV; Folkes LK; Weyer-Czernilofsky U; Bogenrieder T; Ryan AJ; Macaulay VM
    Cancer Res; 2021 Apr; 81(8):2128-2141. PubMed ID: 33509941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair.
    D'Angiolella V; Donato V; Forrester FM; Jeong YT; Pellacani C; Kudo Y; Saraf A; Florens L; Washburn MP; Pagano M
    Cell; 2012 May; 149(5):1023-34. PubMed ID: 22632967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.
    Taricani L; Shanahan F; Malinao MC; Beaumont M; Parry D
    PLoS One; 2014; 9(11):e111714. PubMed ID: 25375241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation regulates ribonucleotide reductase activity and cancer cell growth.
    Chen G; Luo Y; Warncke K; Sun Y; Yu DS; Fu H; Behera M; Ramalingam SS; Doetsch PW; Duong DM; Lammers M; Curran WJ; Deng X
    Nat Commun; 2019 Jul; 10(1):3213. PubMed ID: 31324785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 suppresses ribonucleotide reductase via inhibiting mTORC1.
    He Z; Hu X; Liu W; Dorrance A; Garzon R; Houghton PJ; Shen C
    Oncotarget; 2017 Jun; 8(25):41422-41431. PubMed ID: 28507282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors.
    Goss KL; Koppenhafer SL; Waters T; Terry WW; Wen KK; Wu M; Ostergaard J; Gordon PM; Gordon DJ
    Oncogene; 2021 Jan; 40(3):564-577. PubMed ID: 33191406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinoma.
    Maruyama A; Sato Y; Nakayama J; Murai J; Ishikawa T; Soga T; Makinoshima H
    Sci Rep; 2021 Jun; 11(1):13474. PubMed ID: 34188151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Single Conserved Residue Mediates Binding of the Ribonucleotide Reductase Catalytic Subunit RRM1 to RRM2 and Is Essential for Mouse Development.
    Specks J; Lecona E; Lopez-Contreras AJ; Fernandez-Capetillo O
    Mol Cell Biol; 2015 Sep; 35(17):2910-7. PubMed ID: 26077802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress.
    Croushore EE; Koppenhafer SL; Goss KL; Geary EL; Gordon DJ
    Cancer Res Commun; 2023 Aug; 3(8):1580-1593. PubMed ID: 37599787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of novel 5'-amino gemcitabine analogs as potent RRM1 inhibitors.
    Labroli MA; Dwyer MP; Shen R; Popovici-Muller J; Pu Q; Wyss D; McCoy M; Barrett D; Davis N; Seghezzi W; Shanahan F; Taricani L; Beaumont M; Malinao MC; Parry D; Guzi TJ
    Bioorg Med Chem; 2014 Apr; 22(7):2303-10. PubMed ID: 24588962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase ATR inhibits E3 ubiquitin ligase CRL4
    Bao W; Zhang W; Huang Y; Zhao Y; Wu C; Duan L; Wang L; Yan S
    Cell Rep; 2023 Jul; 42(7):112685. PubMed ID: 37354461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance.
    Abdel-Rahman MA; Mahfouz M; Habashy HO
    Diagn Pathol; 2022 Jan; 17(1):1. PubMed ID: 34986845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RRM1 variants cause a mitochondrial DNA maintenance disorder via impaired de novo nucleotide synthesis.
    Shintaku J; Pernice WM; Eyaid W; Gc JB; Brown ZP; Juanola-Falgarona M; Torres-Torronteras J; Sommerville EW; Hellebrekers DM; Blakely EL; Donaldson A; van de Laar I; Leu CS; Marti R; Frank J; Tanji K; Koolen DA; Rodenburg RJ; Chinnery PF; Smeets HJM; Gorman GS; Bonnen PE; Taylor RW; Hirano M
    J Clin Invest; 2022 Jul; 132(13):. PubMed ID: 35617047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DHS (trans-4,4'-dihydroxystilbene) suppresses DNA replication and tumor growth by inhibiting RRM2 (ribonucleotide reductase regulatory subunit M2).
    Chen CW; Li Y; Hu S; Zhou W; Meng Y; Li Z; Zhang Y; Sun J; Bo Z; DePamphilis ML; Yen Y; Han Z; Zhu W
    Oncogene; 2019 Mar; 38(13):2364-2379. PubMed ID: 30518875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular regulation of ribonucleotide reductase in eukaryotes.
    Guarino E; Salguero I; Kearsey SE
    Semin Cell Dev Biol; 2014 Jun; 30():97-103. PubMed ID: 24704278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.